Objective: Corneal refractive surgery has been gaining popularity among postmenopausal women over the past several years. Previous studies with different methods showed increased adrenergic activity in the postmenopausal period and suppressed sympathetic response with hormone replacement therapy. As pupil size may alter with sympathetic activity, we hypothesized that the success rate of corneal refractive surgery may be affected by hormone replacement therapy. The aim of this study was to evaluate the effects of hormone replacement therapy on pupil diameter. Material and Methods: Sixty-five healthy postmenopausal women who received hormone replacement therapy that was consisted of conjugated estrogen and medroxyprogesteron acetate have participated in this study. Pupil diameter was measured with an infrared pupillometer [OPD-Scan II Pupillometer/Corneal Wavefront Analyser ARK-10000 system (Nidek, Japan)] at the time of study enrollment and atleast 3 months (4.9 ±1.3) after the initiation of hormone replacement therapy. Results: Mean pupil diameters under mesopic/photopic conditions were 5.84±0.86mm/ 4.60±0.79mm before hormone replacement therapy and, 5.85±0.77mm/4.62±0.76 mm after hormone replacement therapy. The differences between 'before hormone replacement therapy' and 'after hormone replacement therapy' assessments were statistically insignificant (p=0,860 ve p=0,552 respectively). Conclusion: The effect of hormone replacement therapy on pupil size, either directly or via autonomic nervous system, was insignificant in postmenopausal women. However, it is recommended that the results of our study need to be confirmed by more detailed studies.
Keywords: Menopause; pupil size; hormone replacement therapy; autonomic nervous system
Amaç: Son yıllarda korneal refraktif cerrahi, postmenopozal kadınlar tarafından da giderek daha fazla rağbet görmektedir. Farklı yöntemler ile yapılan daha önceki birçok çalışma menopoz sonrası dönemde adrenerjik aktivitenin arttığını ve hormon replasman tedavisi ile sempatik cevabın baskılandığını göstermiştir. Pupil çapının sempatik aktivite ile değişkenlik gösterdiği düşünülürse, hormon replasman tedavisinin korneal refraktif cerrahi başarısını etkileyebileceği öngörülmüştür. Bu çalışmanın amacı hormon replasman tedavisinin pupil çaplarına olan etkisini değerlendirmektir. Gereç ve Yöntemler: Konjuge öströjen ve medroksiprogesteron asetat içeren hormon replasman tedavisi kullanan 65 sağlıklı postmenopozal kadın çalışmaya dahil edildi. Pupil çapı, hormon replasman tedavisi kullanımı öncesi ve tedavi başlangıcından en az 3 ay geçtikten sonra (4,9±1,3), infrared pupillometre [OPD-Scan II Pupillometer/ Corneal Wavefront Analyser ARK-10000 sistem (Nidek, Japan)] ile ölçüldü. Bulgular: Mezopik ve fotopik koşullarda ortalama pupil çapları hormon replasman tedavisi öncesi sırasıyla 5,84±0,86 mm /4,60±0,79 mm ve hormon replasman tedavisi sonrası sırasıyla 5,85±0,77 mm / 4,62±0,76 idi. Hormon replasman tedavisi öncesi ve sonrası yapılan pupil çapı ölçümleri arasındaki fark istatistiksel olarak anlamlı değildi (sırasıyla p=0,860 ve p=0,552). Sonuç: Sonuç olarak, çalışmamızda hormon replasman tedavisinin, post menopozal kadınlarda direkt veya otonom sinir sistemi aracılığı ile pupil çapını anlamlı düzeyde etkilemediği saptanmıştır. Ancak, çalışmamızda elde ettiğimiz bu sonuçların çok daha geniş kapsamlı araştırmalarla desteklenmesi gerekmektedir.
Anahtar Kelimeler: Menopoz; pupil çapı; hormon replasman tedavisi; otonom sinir sistemi
- Wilhelm H, Wilhelm B. Clinical applications of pupillography. J Neuroophthalmol. 2003;23(1): 42-9. [Crossref] [PubMed]
- Achiron A, Gur Z, Aviv U, Hilely A, Mimouni M, Karmona L, et al. Predicting refractive surgery outcome: machine learning approach with big data. J Refract Surg. 2017;33(9):592-7. [Crossref] [PubMed]
- Alio JL, Plaza-Puche AB, Férnandez-Buenaga R, Pikkel J, Maldonado M. Multifocal intraocular lenses: an overview. Surv Ophthalmol. 2017;62(5):611-34. [Crossref] [PubMed]
- Arba Mosquera S, Verma S, McAlinden C. Centration axis in refractive surgery. Eye Vis (Lond). 2015;2:4. [Crossref] [PubMed] [PMC]
- Hart EC, Charkoudian N, Joyner MJ, Barnes JN, Curry TB, Casey DP. Relationship between sympathetic nerve activity and aortic wave reflection characteristics in postmenopausal women. Menopause. 2013;20(9):967-72. [Crossref] [PubMed] [PMC]
- Fu P, Gibson CJ, Mendes WB, Schembri M, Huang AJ. Anxiety, depressive symptoms, and cardiac autonomic function in perimenopausal and postmenopausal women with hot flashes: a brief report. Menopause. 2018;25(12):1470-5. [Crossref] [PubMed] [PMC]
- Gautam S, Shankar N, Tandon OP, Goel N. Comparison of cardiac autonomic functions among postmenopausal women with and without hormone replacement therapy, and premenopausal women. Indian J Physiol Pharmacol. 2011;55(4):297-303.
- Maffei S, Mercuri A, Zucchelli GC, Vassalle C. Estrogen therapy effects on different vasoactive factors in recent postmenopausal healthy women. Int J Cardiol. 2006;107(2):194-9. [Crossref] [PubMed]
- Colucci WS, Gimbrone MA Jr, McLaughlin MK, Halpern W, Alexander RW. Increased vascular catecholamine sensitivity and alpha-adrenergic receptor affinity in female and estrogen-treated male rats. Circ Res. 1982;50(6):805-11. [Crossref] [PubMed]
- Dundaroz R, Turkbay T, Erdem U, Congologlu A, Sakallioglu O, Tascilar E. Pupillometric assessment of autonomic nervous system in children with functional enuresis. Int Urol Nephrol. 2009;41(2):231-5. [Crossref] [PubMed]
- Muppidi S, Adams-Huet B, Tajzoy E, Scribner M, Blazek P, Spaeth EB, et al. Dynamic pupillometry as an autonomic testing tool. Clin Auton Res. 2013;23(6):297-303. [Crossref] [PubMed]
- Monaco A, Cattaneo R, Mesin L, Fiorucci E, Pietropaoli D. Evaluation of autonomic nervous system in sleep apnea patients using pupillometry under occlusal stress: a pilot study. Cranio. 2014;32(2):139-47. [Crossref] [PubMed]
- Erdem U, Muftuoglu O, Goktolga U, Dagli S. Effect of hormone replacement therapy in women on ocular refractive status and aberrations. J Refract Surg. 2007;23(6):567-72. [Crossref] [PubMed]
- Del Rio G, Verlardo A, Zizzo G, Marrama P, Della Casa L. Sex differences in catecholamine response to clonidine. Int J Obes Relat Metab Disord. 1993;17(8):465-9.
- Patacchioli FR, Ghiciuc CM, Bernardi M, Dima-Cozma LC, Fattorini L, Squeo MR, et al. Salivary alpha-amylase and cortisol after exercise in menopause: influence of long-term HRT. Climacteric. 2015;18(4):528-35. [Crossref] [PubMed]
- Hoeker GS, Hood AR, Katra RP, Poelzing S, Pogwizd SM. Sex differences in beta-adrenergic responsiveness of action potentials and intracellular calcium handling in isolated rabbit hearts. PLoS One. 2014;9(10):e111411. [Crossref] [PubMed] [PMC]
- McIntosh VJ, Chandrasekera PC, Lasley RD. Sex differences and the effects of ovariectomy on the β-adrenergic contractile response. Am J Physiol Heart Circ Physiol. 2011;301(3): H1127-34. [Crossref] [PubMed] [PMC]
- Yang HY, Firth JM, Francis AJ, Alvarez-Laviada A, MacLeod KT. Effect of ovariectomy on intracellular Ca2+ regulation in guinea pig cardiomyocytes. Am J Physiol Heart Circ Physiol. 2017;313(5):H1031-H43. [Crossref] [PubMed] [PMC]
- Wickham LA, Gao J, Toda I, Rocha EM, Ono M, Sullivan DA. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand. 2000; 78(2):146-53. [Crossref] [PubMed]
- Randazzo A, Nizzola F, Rossetti L, Orzalesi N, Vinciguerra P. Pharmacological management of night vision disturbances after refractive surgery results of a randomized clinical trial. J Cataract Refract Surg. 2005;31(9): 1764-72. [Crossref] [PubMed]
- Malyugin B. Cataract surgery in small pupils. Indian J Ophthalmol. 2017;65(12):1323-8. [Crossref] [PubMed] [PMC]
- Khanani AM, Brown SM, Xu KT. Six-month variability of the dark-adapted pupil diameter. J Cataract Refract Surg. 2005;31(5):987-90. [Crossref] [PubMed]
.: Process List